Common Alternatives to Acyclovir for Herpes Treatment
Acyclovir treats herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections like cold sores, genital herpes, shingles, and chickenpox. Alternatives fall into antiviral classes with similar mechanisms—blocking viral DNA replication—but differ in dosing, bioavailability, and use cases.
Valacyclovir (Valtrex) is the prodrug of acyclovir, offering higher oral bioavailability (55% vs. acyclovir's 15-30%), so patients take it less often (e.g., 500mg twice daily for herpes vs. acyclovir 400mg five times daily).[1] Famciclovir (Famvir) converts to penciclovir, matching valacyclovir's efficacy for shingles and genital herpes but with once-daily options for suppression.[2]
How Valacyclovir and Famciclovir Compare Head-to-Head
| Medication | Prodrug Of | Dosing for Genital Herpes (Outbreak) | Bioavailability | Common Cost (Generic, 30-day Supply) |
|------------|------------|-------------------------------------|-----------------|-------------------------------------|
| Acyclovir | N/A | 400mg 5x/day for 5 days | 15-30% | $10-20 |
| Valacyclovir | Acyclovir | 1g 2x/day for 3 days | 55% | $20-40 |
| Famciclovir | Penciclovir | 250mg 3x/day for 5 days | 77% | $30-60 |
Valacyclovir edges out for convenience in acute outbreaks; famciclovir works faster for shingles pain relief.[3][4]
Topical Options When Oral Isn't Needed
For mild cold sores, penciclovir cream (Denavir) applies every 2 hours, reducing healing time by 1 day vs. placebo.[5] Docosanol (Abreva) is OTC, non-antiviral, and shortens lesions by half a day via envelope disruption.[6] Avoid mixing with prescription topicals.
What About for Special Cases Like Pregnancy or Resistance?
In pregnancy, acyclovir remains first-line due to extensive safety data; valacyclovir is comparable with less frequent dosing.[7] For acyclovir-resistant HSV (rare, ~5% in immunocompromised), foscarnet or cidofovir IV are used, though with kidney toxicity risks.[8]
When to Choose One Over Acyclovir
Switch for poor tolerance (e.g., GI upset from high-dose acyclovir), kidney issues (valacyclovir needs dose adjustment), or faster relief. No generics compete directly on patents—all key players like valacyclovir lost exclusivity years ago.[9]
[1]: CDC Herpes Treatment Guidelines
[2]: Famciclovir Prescribing Info
[3]: NEJM Valacyclovir vs Acyclovir Study
[4]: Cochrane Review on Antivirals
[5]: Penciclovir FDA Label
[6]: Abreva Clinical Data
[7]: ACOG Herpes in Pregnancy
[8]: IDSA HSV Resistance Guidelines
[9]: DrugPatentWatch: Valacyclovir